F. Marmé

723 total citations
4 papers, 58 citations indexed

About

F. Marmé is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, F. Marmé has authored 4 papers receiving a total of 58 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Pathology and Forensic Medicine. Recurrent topics in F. Marmé's work include HER2/EGFR in Cancer Research (2 papers), Cancer Treatment and Pharmacology (2 papers) and Advanced Breast Cancer Therapies (1 paper). F. Marmé is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Cancer Treatment and Pharmacology (2 papers) and Advanced Breast Cancer Therapies (1 paper). F. Marmé collaborates with scholars based in Germany, France and United Kingdom. F. Marmé's co-authors include Andreas Schneeweiß, Michael Golatta, Joerg Heil, Komal Jhaveri, Joachim Rom, Holger Hof, Hermann Brenner, Oh Kyu Yoon, Christof Sohn and Ádám Gondos and has published in prestigious journals such as Annals of Oncology and The Breast.

In The Last Decade

F. Marmé

4 papers receiving 58 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Marmé Germany	3	46	19	12	10	10	4	58
Hana Zahed France	5	41 0.9×	25 1.3×	15 1.3×	12 1.2×	6 0.6×	10	81
Laura Ortelli Switzerland	5	29 0.6×	13 0.7×	7 0.6×	5 0.5×	4 0.4×	6	46
Adrián Nervo Argentina	5	59 1.3×	35 1.8×	13 1.1×	6 0.6×	3 0.3×	12	71
Raquel von Schumann Germany	6	56 1.2×	58 3.1×	20 1.7×	13 1.3×	7 0.7×	12	81
Gilberto Amorim Brazil	5	59 1.3×	47 2.5×	13 1.1×	12 1.2×	8 0.8×	9	81
Judith Fraser United Kingdom	5	54 1.2×	21 1.1×	15 1.3×	4 0.4×	4 0.4×	11	70
Anne Laure Martin France	3	64 1.4×	13 0.7×	26 2.2×	4 0.4×	6 0.6×	5	78
G. Forjaz de Lacerda Portugal	4	50 1.1×	14 0.7×	5 0.4×	3 0.3×	7 0.7×	5	68
Ken Mastris Belgium	4	35 0.8×	31 1.6×	40 3.3×	8 0.8×	8 0.8×	6	84
Nabeel Badri United States	5	50 1.1×	25 1.3×	5 0.4×	7 0.7×	5 0.5×	13	91

Countries citing papers authored by F. Marmé

Since Specialization

Citations

This map shows the geographic impact of F. Marmé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Marmé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Marmé more than expected).

Fields of papers citing papers by F. Marmé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Marmé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Marmé. The network helps show where F. Marmé may publish in the future.

Co-authorship network of co-authors of F. Marmé

This figure shows the co-authorship network connecting the top 25 collaborators of F. Marmé. A scholar is included among the top collaborators of F. Marmé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Marmé. F. Marmé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Marmé, F., Javier Cortés, Patrick Schmid, et al.. (2024). PS3-2 Final OS analysis from the phase 3 TROPiCS-02 study: sacituzumab govitecan in HR+/HER2− metastatic breast cancer. Annals of Oncology. 35. S1314–S1315. 1 indexed citations

2.

Marmé, F., H. S. Rugo, Sara M. Tolaney, et al.. (2022). 214MO Sacituzumab govitecan (SG) efficacy in hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2–) metastatic breast cancer (MBC) by HER2 immunohistochemistry (IHC) status in the phase III TROPiCS-02 study. Annals of Oncology. 33. S635–S636. 19 indexed citations

3.

Michel, Laura L., Manuel Feißt, Michael O. Breckwoldt, et al.. (2022). 1552O Chemotherapy-induced peripheral neuropathy (CIPN) prevention trial evaluating the efficacy of hand-cooling and compression in patients undergoing taxan-based (neo-)adjuvant chemotherapy for primary breast cancer: First results of the prospective, randomized POLAR trial. Annals of Oncology. 33. S1257–S1258. 3 indexed citations

4.

Heil, Joerg, Ádám Gondos, Geraldine Rauch, et al.. (2012). Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit. The Breast. 21(3). 303–308. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact